Stay updated on Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page history; this is a minor system update with no impact on core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoChange DetectedUI updates add a Show glossary option and color-coded change indicators (green for additions, red for deletions) on the study record history page, plus a new Revision: v3.4.0; the No FEAR Act data label and the Revision: v3.3.4 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe history now includes a new revision entry (v3.3.4) and removes the previous entry (v3.3.3), affecting only revision history metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history.SummaryDifference0.1%

- Check73 days agoChange DetectedThe history now shows revision v3.3.2 replacing v3.2.0 in the page header; this is a system version update and does not modify study information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedThe government funding operating status notice banner was removed from the page.SummaryDifference0.5%

Stay in the know with updates to Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.